Valuation BioMarin Pharmaceutical Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 13/03/2026 am IST			5-day change	1st Jan Change
59.07 ^USD	-2.07%		-2.48%	-0.61%

12/03	BioMarin Pharmaceutical Inc. Presents New Data On The Positive Impact Of Early Treatment With VOXZOGO on Proportionality and Arm Span in Children with Achondroplasia	CI
12/03	BioMarin Pharmaceutical Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 02:00 PM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	16,220	19,234	18,162	12,527	11,417	11,361	-	-
Change	-	18.58%	-5.57%	-31.03%	-8.86%	-0.5%	-	-
Enterprise Value (EV) ¹	15,778	19,592	18,176	11,984	10,454	12,471	13,056	12,000
Change	-	24.17%	-7.23%	-34.06%	-12.77%	19.3%	4.69%	-8.09%
P/E ratio	-252x	138x	111x	29.7x	33x	13.7x	10.1x	8.16x
PBR	3.8x	4.25x	3.67x	2.22x	-	-	-	-
PEG	-	-0x	6.9x	0x	-1.8x	0x	0.3x	0.3x
Capitalization / Revenue	8.79x	9.18x	7.51x	4.39x	3.54x	2.96x	2.53x	2.32x
EV / Revenue	8.55x	9.35x	7.51x	4.2x	3.25x	3.25x	2.91x	2.45x
EV / EBITDA	614x	77.9x	69.2x	20.6x	21.4x	14.2x	11.6x	8.54x
EV / EBIT	-192x	131x	115x	24.8x	25.5x	25.9x	8.74x	6.84x
EV / FCF	75.5x	357x	290x	24.6x	14.4x	14.5x	12.1x	9.01x
FCF Yield	1.32%	0.28%	0.34%	4.07%	6.93%	6.9%	8.26%	11.1%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.35	0.75	0.87	2.21	1.8	4.298	5.851	7.242
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,846	2,096	2,419	2,854	3,221	3,833	4,482	4,894
EBITDA ¹	25.7	251.5	262.5	580.6	489	881	1,129	1,405
EBIT ¹	-82.34	149.6	158.1	484.2	409.5	481.9	1,494	1,754
Net income ¹	-64.08	141.6	167.6	426.9	348.9	417.6	1,182	1,449
Net Debt ¹	-442.6	358.5	13.16	-542.6	-963.4	1,111	1,695	639
Reference price ²	88.35	103.49	96.42	65.73	59.43	59.07	59.07	59.07
Nbr of stocks (in thousands)	1,83,593	1,85,849	1,88,368	1,90,583	1,92,114	1,92,323	-	-
Announcement Date	23/02/22	27/02/23	22/02/24	19/02/25	23/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIOMARIN PHARMACEUTICAL INC.	13.74x	3.25x	14.16x	-.--%	1.14TCr
REGENERON PHARMACEUTICALS, INC.	18.91x	4.34x	12.3x	0.52%	7.66TCr
UCB	27.73x	5.51x	15.88x	0.58%	5.54TCr
SAMSUNG BIOLOGICS CO.,LTD.	44.29x	13.36x	24.78x	-.--%	5.05TCr
CSL LIMITED	35.75x	3.62x	10.44x	2.94%	4.81TCr
BIOGEN INC.	15.62x	2.88x	8.36x	-.--%	2.71TCr
MODERNA, INC.	-7.69x	8.33x	-6.19x	-.--%	2.11TCr
INCYTE CORPORATION	14.47x	2.29x	7.24x	-.--%	1.83TCr
INNOVENT BIOLOGICS, INC.	74.56x	8.53x	85.28x	-.--%	1.81TCr
SWEDISH ORPHAN BIOVITRUM AB	638.14x	4.99x	12.75x	-.--%	1.4TCr
Average	87.55x	5.71x	18.50x	0.4%	3.41TCr
Weighted average by Cap.	52.64x	6.00x	16.70x	0.63%